Neumora Therapeutics appoints Lenz as EVP, Head of Research, Development

Neumora Therapeutics (NMRA) announced the appointment of Robert Lenz, M.D., Ph.D., as executive vice president. EVP, head of research and development. Dr. Lenz is a member of Neumora’s Executive Team reporting to Henry Gosebruch, chief executive officer. Dr. Lenz brings 20 years of experience developing novel drugs in areas of significant unmet medical need and vast clinical execution expertise to Neumora. In his most recent role as head of global development at Amgen (AMGN), Dr. Lenz oversaw more than 130 interventional study starts with more than 53,000 patients enrolled in over 50 countries.